• LAST PRICE
    0.9869
  • TODAY'S CHANGE (%)
    Trending Down-0.0481 (-4.6473%)
  • Bid / Lots
    1.0000/ 1
  • Ask / Lots
    1.0600/ 11
  • Open / Previous Close
    1.0100 / 1.0350
  • Day Range
    Low 0.9850
    High 1.0300
  • 52 Week Range
    Low 0.8830
    High 3.3942
  • Volume
    559,426
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.035
TimeVolumeONCY
09:32 ET45251.01
09:33 ET1001.02
09:35 ET15401.03
09:37 ET77981.02
09:39 ET19241.01
09:42 ET43891.0101
09:44 ET50001.02
09:48 ET9571.0199
09:51 ET60001.0199
09:53 ET2001.0185
09:55 ET11561.01
09:57 ET11001.02
10:00 ET4501.0194
10:04 ET2001.011
10:11 ET1201.0101
10:13 ET1001.015
10:18 ET4491.0103
10:20 ET27001.0189
10:22 ET8001.0101
10:24 ET37501.0101
10:26 ET90001.015
10:29 ET10001.015
10:36 ET185911
10:40 ET12001
10:42 ET1001.005
10:44 ET103001.01
10:49 ET138921.0099
11:00 ET109791.01
11:09 ET1001.01
11:18 ET10001.0078
11:21 ET442910.99
11:23 ET11500.9929
11:25 ET121500.990023
11:27 ET119000.99
11:30 ET1000.9858
11:32 ET77460.99
11:34 ET170000.9904
11:36 ET30000.987
11:38 ET20000.98825
11:39 ET37000.9858
11:43 ET47000.9866
11:48 ET1000.9859
11:50 ET8500.987
11:52 ET80790.9891
11:54 ET49960.99
11:56 ET101560.9898
11:57 ET25540.9884
11:59 ET4100.99
12:01 ET11000.99
12:03 ET1000.9884
12:06 ET20000.9876
12:08 ET16130.9876
12:10 ET2500.9877
12:12 ET102000.99
12:14 ET3000.99
12:17 ET1000.9899
12:19 ET22000.9878
12:21 ET83380.9986
12:24 ET4500.99345
12:26 ET6000.99565
12:28 ET19990.9937
12:30 ET14540.98709
12:33 ET13000.987
12:35 ET54000.9868
12:37 ET7000.9877
12:39 ET11000.9875
12:42 ET16000.9875
12:46 ET3000.9876
12:48 ET10000.99
12:50 ET1000.9988
12:51 ET26060.9871
12:55 ET5500.9884
12:57 ET130170.9888
01:00 ET18000.9936
01:02 ET35000.9894
01:04 ET26000.9895
01:06 ET15000.9894
01:08 ET27000.9871
01:09 ET1000.9888
01:11 ET4000.99
01:13 ET43600.98945
01:18 ET11000.99
01:22 ET18000.9899
01:24 ET8000.9898
01:26 ET13990.9872
01:27 ET6000.98995
01:29 ET55230.9946
01:31 ET87950.995
01:33 ET64900.9902
01:36 ET56230.9904
01:38 ET94750.99
01:40 ET42160.99
01:42 ET36940.99
01:44 ET45960.99
01:45 ET38000.992
01:47 ET163120.9905
01:49 ET69500.9899
01:51 ET38000.98805
01:54 ET49000.99
01:56 ET68120.99
01:58 ET60270.99
02:00 ET161040.988
02:02 ET75000.99
02:03 ET89000.99
02:05 ET19850.98995
02:07 ET1000.988699
02:09 ET16300.9871
02:12 ET1000.9871
02:16 ET14360.9893
02:18 ET5280.9871
02:21 ET4000.99
02:27 ET5000.9892
02:32 ET5000.9892
02:34 ET17500.99
02:38 ET20000.98995
02:48 ET2000.9899
02:52 ET6530.99
02:54 ET2890.99
03:03 ET14000.9898
03:06 ET3000.9882
03:08 ET5000.9882
03:12 ET5000.9882
03:14 ET18000.9884
03:15 ET151850.9884
03:17 ET2450.98785
03:19 ET29000.9879
03:21 ET93880.989
03:28 ET12010.9891
03:30 ET3000.9891
03:32 ET24680.9922
03:33 ET17250.99
03:35 ET1010.99
03:37 ET70000.9902
03:39 ET7500.9904
03:44 ET168000.986
03:48 ET29170.99
03:50 ET8020.99
03:53 ET1000.9892
03:55 ET5000.9892
03:57 ET13000.99
04:00 ET78560.9869
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesONCY
Oncolytics Biotech Inc
100.6M
-2.6x
---
United StatesRTGN
RetinalGenix Technologies Inc
54.7M
-28.0x
---
United StatesRPHM
Reneo Pharmaceuticals Inc
54.0M
-0.7x
---
United StatesTLSA
Tiziana Life Sciences Ltd
53.8M
-3.3x
---
United StatesQNCX
Quince Therapeutics Inc
57.4M
-1.7x
---
United StatesAVRO
AVROBIO Inc
58.1M
-12.9x
---
As of 2024-02-24

Company Information

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

Contact Information

Headquarters
1167 Kensington Cres Nw Suite 210 Calgary Alberta Canada T2n 1X7CALGARY, AB, Canada T2R 0C5
Phone
403-670-7377
Fax
403-283-0858

Executives

Independent Chairman of the Board
Wayne Pisano
President, Chief Executive Officer, Director
Matthew Coffey
Chief Financial Officer
Kirk Look
Global Head of Business Development, President, Oncolytics Biotech (U.S.) Inc.
Andrew Guttadauro
Vice President - Product Development
Allison Hagerman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$76.2M
Revenue (TTM)
$0.00
Shares Outstanding
73.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.92
EPS
$-0.37
Book Value
$0.32
P/E Ratio
-2.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.